More on ORIC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ORIC Pharmaceuticals Inc. (NQ:ORIC)
Delayed: 8.49 -0.14 (1.62%)
Prev. Close $8.63  
Open$8.85 
52 Wk High$ 
52 Wk Low$ 
Day High$8.98 
Day Low$8.46 
P/E N/A  
EPS$ 
Volume2,771,346 

Friends, Peers and Foes (?): ARWR, CELC, KALV TVTX (more...)

Jun 11, 2026 04:07 PM Stifel Starts ORIC Pharmaceuticals (ORIC) at Buy
Jun 8, 2026 06:57 AM H.C. Wainwright Reiterates Buy Rating on ORIC Pharmaceuticals (ORIC)
Jun 5, 2026 04:30 PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 27, 2026 04:05 PM ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
May 22, 2026 07:26 AM ORIC Pharmaceuticals (ORIC) Reiterated at Overweight by Cantor Fitzgerald
May 15, 2026 05:51 PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2026 04:41 PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: Venrock Healthcare Capital Partners III, L.P.
May 15, 2026 04:26 PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
May 15, 2026 10:09 AM Form SCHEDULE 13G Oric Pharmaceuticals, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
May 15, 2026 05:10 AM Goldman Sachs Upgrades ORIC Pharmaceuticals (ORIC) to Buy
View All Articles

Entities mentioned with ORIC

View All Entities